Artur Machlenkin
Director Técnico/Científico/I+D en PLURI INC. .
Perfil
Artur Machlenkin is currently the Chief Scientific Officer at Pluri, Inc. He previously worked as the Chief Executive Officer at Pantheon Biosciences Ltd.
and as the Head-Immuno Oncology at Compugen Usa, Inc. Dr. Machlenkin holds a doctorate degree from the Weizmann Institute of Science.
Cargos activos de Artur Machlenkin
| Empresas | Cargo | Inicio |
|---|---|---|
| PLURI INC. | Director Técnico/Científico/I+D | 01/05/2022 |
Antiguos cargos conocidos de Artur Machlenkin.
| Empresas | Cargo | Fin |
|---|---|---|
| Compugen Usa, Inc. | Corporate Officer/Principal | - |
Pantheon Biosciences Ltd.
 Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pantheon Biosciences Ltd. is an Israeli company that develops molecular therapies and tools. The company is based in Yavne, Israel and was founded in 2017. | Director Ejecutivo | - |
Formación de Artur Machlenkin.
| Weizmann Institute of Science | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PLURI INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
| Compugen Usa, Inc. | |
Pantheon Biosciences Ltd.
Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Pantheon Biosciences Ltd. is an Israeli company that develops molecular therapies and tools. The company is based in Yavne, Israel and was founded in 2017. | Commercial Services |
- Bolsa de valores
- Insiders
- Artur Machlenkin
